Muscular Dystrophy Treatment Helps In Managing Symptoms Of The Disease And It Also Slow The Progression Of The Disease
Muscular Dystrophy Treatment |
Muscular dystrophy is a group of genetic disorders that cause
muscles to weaken over time. Different forms of muscular dystrophy begin at
different ages, and symptoms may vary from mild to severe. The condition can result
in the inability to walk, in severe cases the affected person can lose their
ability to walk and develop heart problems. Diagnosis of muscular dystrophy is
important, and proper Treatment is essential to ensure a healthy outcome for
the patient.
Various types of Treatments for Muscular Dystrophy are
available. For example, genetic testing may help determine whether a child
carries a mutated gene that causes Muscular Dystrophy. Those with a family
history of the disease should have newborn screenings completed. Additional
tests include diagnostic imaging, strength and exercise testing, and
electromyography. Depending on the type of Muscular Dystrophy, Treatment may
involve physical therapy, surgery or both.
A patient's healthcare team should include a neurologist with
expertise in neuromuscular diseases, a physical medicine, rehabilitation
specialist, physical and occupational therapists. Muscular
Dystrophy Treatment
should be a lifelong process with regular appointments to a team of healthcare
professionals.
Diagnostic tests are necessary to properly diagnose Muscular
Dystrophy, as it helps the physician in gathering a complete birth and prenatal
history. Blood tests and genetic tests may be ordered to confirm a diagnosis.
Muscle biopsy is the primary diagnostic test, and is performed to examine a
small sample of muscle tissue. Another type of test is an electromyogram, which
tests the heart function and muscle weakness.
Along with physical therapy that a patient receives, they may
also benefit from a pediatric physical therapy program. Physical therapy should
begin as soon as the child is diagnosed, before joint tightness develops.
Physical therapists help identify and manage muscle weakness, reduce
contractures, and encourage movement. Often, physical therapists work closely
with the child and their family to ensure that the child is as comfortable as
possible during Treatment.
In January 2021, Taiho Pharmaceutical Co., Ltd. declared that
they are initiating the phase III clinical trial of their drug, TAS-205 for Muscular
Dystrophy in Japan.
Comments
Post a Comment